Results 31 to 40 of about 5,067,029 (185)
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. [PDF]
Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder caused by an expanded CAG repeat in the gene encoding huntingtin (HTT). Therapeutic approaches to lower mutant HTT (mHTT) levels are expected to proceed to human trials, but ...
Salman Haider +55 more
core +1 more source
Visual system integrity and cognition in early Huntington's disease [PDF]
Posterior cortical volume changes and abnormal visuomotor performance are present in patients with Huntington's disease (HD). However, it is unclear whether posterior cortical volume loss contributes to abnormal neural activity, and whether activity ...
Landwehrmeyer, G Bernhard +38 more
core +1 more source
Clinical presentation of juvenile Huntington disease [PDF]
OBJECTIVE: To describe the clinical presentation a group of patients with juvenile onset of Huntington disease. METHOD: All patients were interviewed following a structured clinical questioner. Patients were genotyped for the trinucleotide cytosine-adenine-guanine (CAG) repeat in the Huntington Disease gene.
Ruocco, Heloísa H. +4 more
openaire +5 more sources
The pathophysiology of Huntington's disease (HD) is primarily associated with striatal degeneration and a number of behavioral symptoms such as involuntary movements, cognitive decline, psychiatric disorders, and in the most juvenile-onset cases with ...
Michele Pignatelli +3 more
doaj +1 more source
Huntington’s disease (HD) is an inherited neurodegenerative disease caused by expansion of cytosine–adenine–guanine (CAG) repeats in the huntingtin gene, which leads to neuronal loss and decline in cognitive and motor function.
Raleigh M. Linville +5 more
doaj +1 more source
Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review [PDF]
ABSTRACTHuntington disease is an autosomal dominant inherited brain disorder that typically becomes manifest in adulthood. Juvenile‐onset Huntington disease refers to approximately 5% of patients with symptom onset before the age of 21 years. The causal factor is a pathologically expanded CAG repeat in the Huntingtin gene.
Bakels, H.S. +3 more
openaire +3 more sources
The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington’s Disease
There is a known negative association between cytosine–adenine–guanine (CAG) repeat length and the age of motor onset (AMO) in adult-onset Huntington’s Disease (AOHD).
Jordan L. Schultz +2 more
doaj +1 more source
Short-interval observational data to inform clinical trial design in Huntington's disease. [PDF]
OBJECTIVES: To evaluate candidate outcomes for disease-modifying trials in Huntington's disease (HD) over 6-month, 9-month and 15-month intervals, across multiple domains.
Roos, Raymund AC +59 more
core +1 more source
Huntington's Disease (HD) is a devastating disorder characterized by a triad of motor, psychiatric and cognitive manifestations. Psychiatric and emotional symptoms appear at early stages of the disease which are consistently described by patients and ...
Ened Rodríguez-Urgellés +7 more
doaj +1 more source
Objective: Depression and anxiety significantly affect morbidity in Huntington's disease. Mice.models of Huntington's disease have identified sex differences in mood-like behaviours that vary across disease lifespan, but this interaction has not ...
Shimozaki, Steve +6 more
core +1 more source

